K

Kyowa Kirin

Global specialty pharma focused on antibodies

Value & Access Associate Director

Corporate StrategyConfirmed live in the last 24 hours
Full-timeMadrid, Spain€91.4k - €137.1k /yrIn-person

About the Job

Requirements

  • Significant pharmaceutical industry experience in Market Access, Pricing, Reimbursement, or Health Economics.
  • Strong understanding of the Iberian healthcare landscape and reimbursement processes.
  • Proven ability to influence senior stakeholders and navigate complex healthcare systems.
  • Experience developing successful market access strategies and negotiating with external decision-makers.
  • Strong leadership, strategic thinking, and project management skills.
  • Fluency in English and proficiency in a local language.

Responsibilities

  • Develop and execute market access, pricing, and reimbursement strategies across Iberia.
  • Build and manage relationships with health authorities, payers, policymakers, and key external stakeholders.
  • Lead value demonstration initiatives, health economics projects, and access programs.
  • Shape government affairs and healthcare policy engagement strategies.
  • Provide strategic input into product launches, portfolio planning, and business development opportunities.
  • Lead and develop the local Market Access team while driving cross-functional collaboration.

About the Company

Kyowa Kirin

Global specialty pharma focused on antibodies

1) What does this company do? Kyowa Kirin develops specialty pharmaceutical drugs with a focus on nephrology, oncology, and immunology, built on a foundation of fermentation technology and antibody science. 2) How does this company's product(s) work? It uses fermentation-derived biology and antibody-based approaches to create therapies that target kidney disease, cancer, and immune-related conditions, delivered as approved medicines after research, development, and clinical testing. 3) How is this company different from its competitors? It blends deep fermentation and microbiology expertise with antibody technology from its history, plus a global specialty-drug focus, resulting from a merger of Kyowa Hakko Kogyo and Kirin Pharma that combined fermentation know-how with pharmaceutical resources. 4) What is this company's goal? To develop and commercialize innovative treatments that address unmet medical needs in nephrology, oncology, and immunology on a global scale.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Tokyo, Japan
Founded
1885

Recently Posted Jobs

Explore more opportunities at Kyowa Kirin

See more jobs